tbuckley/cabot-search huggingface dataset:
Theranostic Approach in Breast Cancer
Authors: Narges Jokar, Irina Velikyan, Hojjat Ahmadzadehfar, Seyed Javad Rekabpour, Esmail Jafari, Hong Hoi Ting, Hans-Jürgen Biersack, Majid Assadi
Journal: Clinical Nuclear Medicine (2021)

Breast cancer is the most frequent invasive malignancy and the second major cause of cancer death in female subjects mostly due to the considerable diagnostic delay and failure of therapeutic strategies. Thus, early diagnosis and possibility to monitor response to the treatment are of utmost importance. Identification of valid biomarkers, in particular new molecular therapeutic targets, that would allow screening, early patient identification, prediction of disease aggressiveness, and monitoring response to the therapeutic regimen has been in the focus of breast cancer research during recent decades. One of the intensively developing fields is nuclear medicine combining molecular diagnostic imaging and subsequent (radio)therapy in the light of theranostics. This review aimed to survey the current status of preclinical and clinical research using theranostic approach in breast cancer patients with potential to translate into conventional treatment strategies alone or in combination with other common treatments, especially in aggressive and resistant types of breast cancer. In addition, we present 5 patients with breast cancer who were refractory or relapsed after conventional therapy while presumably responded to the molecular radiotherapy with 177Lu-trastuzumab (Herceptin), 177Lu-DOTATATE, and 177Lu-FAPI-46.
Recurrent Severe Preschool Wheeze: From Prespecified Diagnostic Labels to Underlying Endotypes
Authors: Polly F. M. Robinson, Sara Fontanella, Sachin Ananth, Aldara Martin Alonso, James Cook, Daphne Kaya-de Vries, Luisa Polo Silveira, Lisa Gregory, Clare Lloyd, Louise Fleming, Andrew Bush, Adnan Custovic, Sejal Saglani
Journal: American Journal of Respiratory and Critical Care Medicine (2021)

Rationale: Preschool wheezing is heterogeneous, but the underlying mechanisms are poorly understood.Objectives: To investigate lower airway inflammation and infection in preschool children with different clinical diagnoses undergoing elective bronchoscopy and BAL.Methods: We recruited 136 children aged 1-5 years (105 with recurrent severe wheeze [RSW]; 31 with nonwheezing respiratory disease [NWRD]). Children with RSW were assigned as having episodic viral wheeze (EVW) or multiple-trigger wheeze (MTW). We compared lower airway inflammation and infection in different clinical diagnoses and undertook data-driven analyses to determine clusters of pathophysiological features, and we investigated their relationships with prespecified diagnostic labels.Measurements and Main Results: Blood eosinophil counts and percentages and allergic sensitization were significantly higher in children with RSW than in children with a NWRD. Blood neutrophil counts and percentages, BAL eosinophil and neutrophil percentages, and positive bacterial culture and virus detection rates were similar between groups. However, pathogen distribution differed significantly, with higher detection of rhinovirus in children with RSW and higher detection of Moraxella in sensitized children with RSW. Children with EVW and children with MTW did not differ in terms of blood or BAL-sample inflammation, or bacteria or virus detection. The Partition around Medoids algorithm revealed four clusters of pathophysiological features: 1) atopic (17.9%), 2) nonatopic with a low infection rate and high use of inhaled corticosteroids (31.3%), 3) nonatopic with a high infection rate (23.1%), and 4) nonatopic with a low infection rate and no use of inhaled corticosteroids (27.6%). Cluster allocation differed significantly between the RSW and NWRD groups (RSW was evenly distributed across clusters, and 60% of the NWRD group was assigned to cluster 4; P < 0.001). There was no difference in cluster membership between the EVW and MTW groups. Cluster 1 was dominated by Moraxella detection (P = 0.04), and cluster 3 was dominated by Haemophilus or Staphylococcus or Streptococcus detection (P = 0.02).Conclusions: We identified four clusters of severe preschool wheeze, which were distinguished by using sensitization, peripheral eosinophilia, lower airway neutrophilia, and bacteriology.
Targeting AMPK by Statins: A Potential Therapeutic Approach
Authors: Sajad Dehnavi, Amirhossein Kiani, Mahvash Sadeghi, Ali Farhadi Biregani, Maciej Banach, Stephen L. Atkin, Tannaz Jamialahmadi, Amirhossein Sahebkar
Journal: Drugs (2021)

Statins are a group of lipid-lowering drugs that inhibit cholesterol biosynthesis and have anti-inflammatory, anti-tumor, and immunomodulatory properties. Several lines of evidence indicate that statins regulate multiple proteins associated with the regulation of differing cellular pathways. The 5′-adenosine monophosphate-activated protein kinase (AMPK) pathway plays an important role in metabolism homeostasis with effects on cellular processes including apoptosis and the inflammatory responses through several pathways. Recently, it has been shown that statins can affect the AMPK pathway in differing physiological and pathological ways, resulting in anti-cancer, cardio-protective, neuro-protective, and anti-tubercular effects; additionally, they have therapeutic effects on non-alcoholic fatty liver disease and diabetes mellitus-associated complications. Statins activate AMPK as an energy sensor that inhibits cell proliferation and induces apoptosis in cancer cells, whilst exerting its cardio-protective effects through inhibition of inflammation and fibrosis, and promotion of angiogenesis. Furthermore, statin-associated AMPK activation leads to decreased lipid accumulation and decreased amyloid beta deposition in the liver and brain, respectively, and may have therapeutic effects on the liver and neurons. In this review, we summarize the results of studies of AMPK-associated therapeutic effects of statins in different pathological conditions.
Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data
Authors: Toshi A Furukawa, Aya Suganuma, Edoardo G Ostinelli, Gerhard Andersson, Christopher G Beevers, Jason Shumake, Thomas Berger, Florien Willemijn Boele, Claudia Buntrock, Per Carlbring, Isabella Choi, Helen Christensen, Andrew Mackinnon, Jennifer Dahne, Marcus J H Huibers, David D Ebert, Louise Farrer, Nicholas R Forand, Daniel R Strunk, Iony D Ezawa, Erik Forsell, Viktor Kaldo, Anna Geraedts, Simon Gilbody, Elizabeth Littlewood, Sally Brabyn, Heather D Hadjistavropoulos, Luke H Schneider, Robert Johansson, Robin Kenter, Marie Kivi, Cecilia Björkelund, Annet Kleiboer, Heleen Riper, Jan Philipp Klein, Johanna Schröder, Björn Meyer, Steffen Moritz, Lara Bücker, Ove Lintvedt, Peter Johansson, Johan Lundgren, Jeannette Milgrom, Alan W Gemmill, David C Mohr, Jesus Montero-Marin, Javier Garcia-Campayo, Stephanie Nobis, Anna-Carlotta Zarski, Kathleen O'Moore, Alishia D Williams, Jill M Newby, Sarah Perini, Rachel Phillips, Justine Schneider, Wendy Pots, Nicole E Pugh, Derek Richards, Isabelle M Rosso, Scott L Rauch, Lisa B Sheeber, Jessica Smith, Viola Spek, Victor J Pop, Burçin Ünlü, Kim M P van Bastelaar, Sanne van Luenen, Nadia Garnefski, Vivian Kraaij, Kristofer Vernmark, Lisanne Warmerdam, Annemieke van Straten, Pavle Zagorscak, Christine Knaevelsrud, Manuel Heinrich, Clara Miguel, Andrea Cipriani, Orestis Efthimiou, Eirini Karyotaki, Pim Cuijpers
Journal: The Lancet Psychiatry (2021)
IMPACT OF ATRIAL FIBRILLATION ON EMBOLIC HIGH-INTENSITY TRANSIENT SIGNALS DURING TAVI. A TRANSCRANIAL DOPPLER STUDY
Authors: Charalampos Kalantzis, Michael Vavuranakis, Konstantinos Kalogeras, Evangelia Bei, Carmen Maria Moldovan, Efstratios Katsianos, Gerasimos Siasos, Dimitris Tousoulis, Konstantinos Tsioufis, Manolis Vavuranakis
Journal: Journal of the American College of Cardiology (2021)
HIGH-DENSITY LIPOPROTEIN FUNCTION IN PATIENTS WITH TYPE 2 DIABETES: DIFFERENCES BETWEEN THE ACUTE AND CHRONIC PHASES OF CORONARY ARTERY DISEASE
Authors: Paulo Rizzo Genestreti, Fatima R. Freitas, Remo Furtado, Rocio Salsoso Rodriguez, Talia Dalcoquio, Thauany Tavoni, Carlos Nakashima, Aline Gehlen Ferrari, Raiza Colodetti, Fernando Menezes, Viviane Lima, Luciano Baracioli, Raul C. Maranhao, Jose Nicolau
Journal: Journal of the American College of Cardiology (2021)
EFFICACY AND SAFETY OF FIBRINOLYSIS VERSUS SURGERY FOR MANAGEMENT OF PROSTHETIC VALVE THROMBOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Sapan Bhuta, Neha Patel, Omar Sajdeya, Mohammed Mhanna, Pinang Shastri, Cameron Burmeister, Jeremy Tomcho, Mitra Patel, Ahmed Elzanaty, Azizullah Beran, Sami Ghazaleh
Journal: Journal of the American College of Cardiology (2021)
PREVALENCE OF MYOCARDIAL EDEMA WITH T2 MAPPING IN HYPERTROPHIC CARDIOMYOPATHY
Authors: Mirza Baig, Patrycja Galazka, Omar Dakwar, Sameh A. Syed, Rahul Sawlani, Kaushik Shahir, Lakshmi Muthukumar, Renuka Jain, M. Fuad Jan, Steven Port, Bijoy Khandheria, Arshad Jahangir, A. Jamil Tajik
Journal: Journal of the American College of Cardiology (2021)
IMPACT OF FRAILTY ON MORTALITY AND QUALITY OF LIFE OUTCOMES IN ONCOLOGY PATIENTS UNDERGOING TAVR
Authors: Nikitha Kosaraju, Perry Wu, Asim Rafique, Marielle Bolano, Deena Goldwater, Olcay Aksoy, John Shen, Nancy Satou, Jeanne Huchting, Eric Yang
Journal: Journal of the American College of Cardiology (2021)
TEMPORAL TRENDS IN PATIENT CHARACTERISTICS, MANAGEMENT, AND OUTCOMES AMONG PATIENTS ADMITTED FOR PRIMARY CARDIAC TUMORS: RESULTS FROM THE NATIONAL INPATIENT SAMPLE
Authors: Joseph Heaton, Alexis Okoh, Nehal Dhaduk, Khoi P. Dang-Ho, Rajiv Tayal, Arash Salemi, Sergio Waxman
Journal: Journal of the American College of Cardiology (2021)
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
Authors: Daniel J. Olson, Zeynep Eroglu, Bruce Brockstein, Andrew S. Poklepovic, Madhuri Bajaj, Sunil Babu, Sigrun Hallmeyer, Mario Velasco, Jose Lutzky, Emily Higgs, Riyue Bao, Timothy C. Carll, Brian Labadie, Thomas Krausz, Yuanyuan Zha, Theodore Karrison, Vernon K. Sondak, Thomas F. Gajewski, Nikhil I. Khushalani, Jason J. Luke
Journal: Journal of Clinical Oncology (2021)

PURPOSE Combination of antiprogrammed cell death protein-1 (PD-1) plus anti–cytotoxic T-cell lymphocyte-4 (anti-CTLA-4) immunotherapy shows greater response rates (RRs) than anti-PD-1 antibody alone in melanoma, but RR after initial anti-PD-1 and programmed death ligand-1 (PD-L1) antibody progression awaits robust investigation. Anti-CTLA-4 antibody alone after anti-PD-1/L1 antibody progression has a historical RR of 13%. We report the results of the first prospective clinical trial evaluating ipilimumab 1 mg/kg plus pembrolizumab following progression on anti-PD-1 immunotherapy. METHODS Patients with advanced melanoma who had progressed on anti-PD-1/L1 antibody as immediate prior therapy (including non–anti-CTLA-4 antibody combinations) were eligible. Patients received pembrolizumab 200 mg plus ipilimumab 1 mg/kg once every 3 weeks for four doses, followed by pembrolizumab monotherapy. The primary end point was RR by irRECIST. After 35 patients, the trial met the primary end point and was expanded to enroll a total of 70 patients to better estimate the RR. RESULTS Prior treatments included 60 on anti-PD-1 antibody alone and 10 on anti-PD-1/L1 antibody–based combinations. Thirteen patients had progressed in the adjuvant setting. The median length of prior treatment with anti-PD-1/L1 antibody was 4.8 months. Response assessments included five complete and 15 partial responses, making the irRECIST RR 29% among the entire trial population. The median progression-free survival was 5.0 months, and the median overall survival was 24.7 months. The median duration of response was 16.6 months. There was no difference in median time on prior anti-PD1/L1 or time to PD1 + CTLA4 initiation between responders and nonresponders. Grade 3-4 drug-related adverse events occurred in 27% of patients. Responses occurred in PD-L1–negative, non-T-cell–inflamed, and intermediate tumor phenotypes. CONCLUSION To our knowledge, this is the first prospective study in melanoma of pembrolizumab plus low-dose ipilimumab after anti-PD-1/L1 immunotherapy failure, demonstrating significant antitumor activity and tolerability.
Endoscopic coloenterostomy for treatment of malignant small-bowel obstruction: troubleshooting and management of complications
Authors: Mihajlo Gjeorgjievski, Abdelhai Abdelqader, Avik Sarkar, Haroon Shahid, Amy Tyberg, Michel Kahaleh
Journal: Endoscopy (2021)

A 66-year-old woman with a past medical history of metastatic pancreatic cancer with peritoneal carcinomatosis presented to the hospital with 1-week history of worsening abdominal pain, distension, nausea, and vomiting. Computed tomography (CT) revealed a malignant-appearing thickening of the small bowel, causing obstruction with a transition point at the distal ileal loop ([Fig. 1]). A nasogastric tube was placed on low intermittent suction for immediate symptomatic treatment. The patient was deemed a poor surgical candidate due to extensive metastatic disease, however she was willing to pursue further options to resolve her small-bowel obstruction and ultimately resume chemotherapy. Therefore, upon multidisciplinary agreement and patient consent, we decided to proceed with an attempt for an endoscopic ultrasound (EUS)-guided coloenterostomy, bypassing the malignant small-bowel obstruction.
LEFT ATRIAL APPENDAGE OCCLUSION USING INTRACARDIAC ECHOCARDIOGRAPHY VERSUS TRANSOESOPHAGEAL ECHOCARDIOGRAPHY, A SINGLE OPERATOR, MULTICENTRE RETROSPECTIVE REVIEW
Authors: Kevin Millar, Myles McKittrick, Rory Gallen, YiXuan Goh, Thomas Kiernan, Samer Arnous
Journal: Journal of the American College of Cardiology (2021)
ECHOCARDIOGRAPHY PERFORMANCE CHARACTERISTICS FOR BAFFLE COMPLICATIONS IN PATIENTS WITH D-TRANSPOSITION OF THE GREAT ARTERIES AND ATRIAL SWITCH OPERATION
Authors: Brian La Starza, Darren Harrison, Christopher Broda, Dhaval Parekh, Athar Qureshi, Srinath Gowda, Peter Ermis, Angeline Opina, Shivani Aggarwal, Stephen Dolgner, Wilson Lam
Journal: Journal of the American College of Cardiology (2021)
Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection
Authors: Bibo Zhu, Yue Wu, Su Huang, Ruixuan Zhang, Young Min Son, Chaofan Li, In Su Cheon, Xiaochen Gao, Min Wang, Yao Chen, Xian Zhou, Quynh Nguyen, Anthony T. Phan, Supriya Behl, M. Mark Taketo, Matthias Mack, Virginia S. Shapiro, Hu Zeng, Hideki Ebihara, John J. Mullon, Eric S. Edell, Janani S. Reisenauer, Nadir Demirel, Ryan M. Kern, Rana Chakraborty, Weiguo Cui, Mark H. Kaplan, Xiaobo Zhou, Ananda W. Goldrath, Jie Sun
Journal: Immunity (2021)
HYPERTROPHIC CARDIOMYOPATHY WITHOUT HYPERTROPHY: MASQUERADERS OF OUTFLOW OBSTRUCTIVE PHYSIOLOGY WITH NORMAL LV MASS
Authors: Adee Elhamdani, Jian Hu, Kirtivardhan Vashistha, Abhas Khurana, Pietro Bajona, Jennifer Keeley, Srinivas Murali, Craig Alpert, Vinh Nguyen
Journal: Journal of the American College of Cardiology (2021)
IMPACT OF NEW-ONSET ATRIAL FIBRILLATION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN RURAL AMERICA: THE STAT-HEART PROGRAM REGISTRY
Authors: Ramtej Atluri, Mouna Kodali, Bharath Rajagopalan, Frank Aguirre, Ziad Issa
Journal: Journal of the American College of Cardiology (2021)
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
Authors: Xiaojun Wu, Xiaofan Liu, Yilu Zhou, Hongying Yu, Ruiyun Li, Qingyuan Zhan, Fang Ni, Si Fang, Yang Lu, Xuhong Ding, Hailing Liu, Rob M Ewing, Mark G Jones, Yi Hu, Hanxiang Nie, Yihua Wang
Journal: The Lancet Respiratory Medicine (2021)
ACUTE PULMONARY EMBOLISM DURING PREGNANCY AND PUERPERIUM. A NATIONWIDE ANALYSIS
Authors: Ahmed Elkaryoni, Ivo Genev, Mahmoud Salem, Ain Ejaz, Joshua Newman, Sorcha Allen, May Bakir, Yevgeniy Brailovsky, Matthew Bunte, Amir Darki
Journal: Journal of the American College of Cardiology (2021)
Primary results of long‐term outcomes in the <scp>MOMENTUM</scp> 3 pivotal trial and continued access protocol study phase: a study of 2200 <scp>HeartMate</scp> 3 left ventricular assist device implants
Authors: Mandeep R. Mehra, Joseph C. Cleveland, Nir Uriel, Jennifer A. Cowger, Shelley Hall, Douglas Horstmanshof, Yoshifumi Naka, Christopher T. Salerno, Joyce Chuang, Christopher Williams, Daniel J. Goldstein
Journal: European Journal of Heart Failure (2021)

The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left ventricular assist device (LVAD), a fully magnetically levitated centrifugal-flow pump, over the HeartMate II axial-flow pump. We now evaluate HM3 LVAD outcomes in a single-arm prospective continuous access protocol (CAP) post-pivotal trial study.We enrolled 2200 HM3 implanted patients (515 pivotal trial and 1685 CAP patients) and compared outcomes including survival free of disabling stroke or reoperation to replace or remove a malfunctioning device (primary composite endpoint), overall survival and major adverse events at 2 years. The 2-year primary endpoint [76.7% vs. 74.8%; adjusted hazard ratio (HR) 0.87, 95% confidence interval (CI) 0.71-1.08, P = 0.21] and overall survival (81.2% vs. 79.0%) were similar among CAP and pivotal cohorts despite sicker patients (more intra-aortic balloon pump use and INTERMACS profile 1) in CAP who were more often intended for destination therapy. Survival was similar between the CAP and pivotal trial in transplant ineligible patients (79.1% vs. 76.7%; adjusted HR 0.89, 95% CI 0.68-1.16, P = 0.38). In a pooled analysis, the 2-year primary endpoint was similar between INTERMACS profiles 1-2 ('unstable' advanced heart failure), profile 3 ('stable' on inotropic therapy), and profiles 4-7 ('stable' ambulatory advanced heart failure) (75.7% vs. 77.6% vs. 72.9%, respectively). The net burden of adverse events was lower in CAP (adjusted rate ratio 0.93, 95% CI 0.88-0.98, P = 0.006), with consequent decrease in hospitalization.The primary results of accumulating HM3 LVAD experience suggest a lower adverse event burden and similar survival compared to the pivotal MOMENTUM 3 trial.
Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019
Authors: Marie-Louise von Linstow, Alex Yde Nielsen, Nikolai Kirkby, Anna Eltvedt, Thilde Nordmann Winther, Allan Bybeck Nielsen, Didi Bang, Anja Poulsen
Journal: Eurosurveillance (2021)

Background Healthcare workers (HCW) have been identified as index cases in disease outbreaks of vaccine-preventable diseases (VPD) in hospitals. Aim We investigated whether Danish paediatric HCW were protected against selected serious VPD. Methods We included 90% of staff members from two paediatric departments. All 555 HCW (496 women) supplied a blood sample for serology and filled in a questionnaire. Antibodies were measured with enzyme immunoassay against measles, mumps, rubella (MMR), varicella zoster, pertussis toxin and diphtheria toxin. Results Protective levels of IgG were found for measles (90.3%), mumps (86.5%), rubella (92.3%), varicella (98.6%) and diphtheria (80.5%). We found seropositivity for all three MMR components in 421 (75.9%) HCW, lowest in those younger than 36 years (63.3%). Only 28 (5%) HCW had measurable IgG to pertussis. HCW with self-reported immunity defined as previous infection or vaccination, had protective levels of IgG against measles, mumps, rubella and varicella in 87.4–98.8% of cases, not significantly higher than in those not reporting immunity. Previous history of disease had a high positive predictive value (PPV) of 96.8–98.8%. The PPV for previous vaccination ranged from 82.5% to 90.3%. In contrast, negative predictive values of self-reported history of disease and vaccination were remarkably low for all diseases. Conclusion The immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW’s immune status in order to identify those who would benefit from vaccination.
THE “VEILED” ST-ELEVATION MYOCARDIAL INFARCTION (STEMI): DIAGNOSING AN ACUTE POSTERIOR STEMI (POSTERIOR MYOCARDIAL INFARCTION) WITH REMOTE Q WAVE INFERIOR MI
Authors: Aayush Shah, Adriana Mares, Amogh Misra, ANIL JHA, Rakhee R Makhija, Ranjan Dahal, Haider Alkhateeb, Harsha Nagarajarao, Kazue Okajima, Ahmed Ibrahim, Chandra Ojha
Journal: Journal of the American College of Cardiology (2021)
Should Thiotepa-Based Regimens Be the New Transplant Conditioning Strategy for Primary Central Nervous System Lymphoma?
Authors: John M. Hill, Kenneth R. Meehan
Journal: JAMA Oncology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Rising Black voices in urology — the next generation
Authors: Justin K. Achua, Jordan Bilbrew, Keiko Cooley, Amber Herbert, Asia N. Matthew-Onabanjo, Odinachi Moghalu, Akya Myrie, Nkiruka Odeluga, Jeunice Owens-Walton, Arriana Rieland, Dyvon Walker, Aboubacar Kaba
Journal: Nature Reviews Urology (2021)